C
FLGT icon

Covestor’s Fulgent Genetics FLGT Stock Holding History

Covestor’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
25
-3
-11% -$51 ﹤0.01% 2152
2026
Q1 		$0 Sell
28
-30
-52% -$651 ﹤0.01% 2426
2025
Q4 		$2K Sell
58
-41
-41% -$1.06K ﹤0.01% 1914
2025
Q3 		$2K Buy
99
+24
+32% +$494 ﹤0.01% 1941
2025
Q2 		$1K Buy
75
+61
+436% +$1.19K ﹤0.01% 1987
2025
Q1 		$0 Buy
14
+2
+17% +$34 ﹤0.01% 2391
2024
Q4 		$0 Hold
12
– – ﹤0.01% 2401
2024
Q3 		$0 Hold
12
– – ﹤0.01% 2385
2024
Q2 		$0 Sell
12
-1,328
-99% -$27.7K ﹤0.01% 2399
2024
Q1 		$29K Buy
1,340
+22
+2% +$546 0.02% 1076
2023
Q4 		$38K Sell
1,318
-190
-13% -$5.08K 0.03% 963
2023
Q3 		$40K Buy
1,508
+489
+48% +$16.7K 0.03% 865
2023
Q2 		$38K Buy
1,019
+834
+451% +$29.1K 0.03% 889
2023
Q1 		$6K Buy
185
+47
+34% +$1.51K 0.01% 1511
2022
Q4 		$4K Buy
138
+58
+73% +$2.08K ﹤0.01% 1617
2022
Q3 		$3K Sell
80
-15
-16% -$752 ﹤0.01% 1611
2022
Q2 		$5K Buy
95
+31
+48% +$1.7K ﹤0.01% 1402
2022
Q1 		$4K Buy
64
+17
+36% +$1.12K ﹤0.01% 1529
2021
Q4 		$5K Buy
+47
New +$4.13K 0.01% 1302

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Covestor's FLGT Position: Q2 2026 in Review

Covestor reduced its Fulgent Genetics (FLGT) stake by 11% in Q2 2026, selling an estimated $51 and leaving 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2152.

Covestor first reported a position in FLGT in Q4 2021 and has held it in 19 quarters since. The position peaked at $40K in Q3 2023. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Covestor held 25 shares of Fulgent Genetics worth $1K as of Q2 2026.
  • Covestor sold 3 Fulgent Genetics shares in Q2 2026, an estimated $51.
  • Fulgent Genetics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2152 holding.
  • Covestor first reported a position in Fulgent Genetics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Fulgent Genetics position peaked at $40K in Q3 2023.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.